TMCI (STOCKS)
Treace Medical Concepts, Inc. Common Stock
$4.100000
+0.040000 (+0.99%)
Prev close: $4.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John T. Treace
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $253.98M
- Employees
- 477
- P/E (TTM)
- -4.09
- P/B (TTM)
- 3.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
5
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.28 | $-0.31 | +0.0342 | +10.88% |
|
Dec 2025 (Q4)
|
$-0.15 | $-0.15 | +0.0030 | +1.96% |
|
Sep 2025 (Q3)
|
$-0.26 | $-0.29 | +0.0256 | +8.96% |
|
Jun 2025 (Q2)
|
$-0.28 | $-0.29 | +0.0141 | +4.79% |
Financial Statements
| Revenues | $207.32M |
| Benefits Costs and Expenses | $137.07M |
| Cost Of Revenue | $42.05M |
| Costs And Expenses | $267.32M |
| Gross Profit | $165.27M |
| Operating Expenses | $221.01M |
| Research and Development | $19.34M |
| Other Operating Expenses | $201.66M |
| Operating Income/Loss | -$55.74M |
| Income/Loss From Continuing Operations After Tax | -$61.04M |
| Income/Loss From Continuing Operations Before Tax | $5.46M |
| Interest Expense, Operating | $5.58M |
| Net Income/Loss | -$61.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$61.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$61.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.96 |
| Diluted Earnings Per Share | -$0.96 |
| Basic Average Shares | 191,314,137 |
| Diluted Average Shares | 191,314,137 |
| Assets | $184.10M |
| Current Assets | $123.47M |
| Inventory | $36.37M |
| Other Current Assets | $87.11M |
| Noncurrent Assets | $60.63M |
| Fixed Assets | $32.06M |
| Intangible Assets | $6.89M |
| Other Non-current Assets | $21.68M |
| Liabilities | $106.91M |
| Current Liabilities | $34.49M |
| Accounts Payable | $13.54M |
| Wages | $5.62M |
| Other Current Liabilities | $15.33M |
| Noncurrent Liabilities | $72.42M |
| Long-term Debt | $55.82M |
| Other Non-current Liabilities | $16.60M |
| Equity | $77.19M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $77.19M |
| Liabilities And Equity | $184.10M |
| Net Cash Flow From Operating Activities | -$12.93M |
| Net Cash Flow From Operating Activities, Continuing | -$12.93M |
| Net Cash Flow From Investing Activities | $7.33M |
| Net Cash Flow From Investing Activities, Continuing | $7.33M |
| Net Cash Flow From Financing Activities | $1.77M |
| Net Cash Flow From Financing Activities, Continuing | $1.77M |
| Net Cash Flow | -$3.83M |
| Net Cash Flow, Continuing | -$3.83M |
| Comprehensive Income/Loss | -$61.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$61.12M |
| Other Comprehensive Income/Loss | -$16.36M |